Clinical Trial Update: Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

View source ↗

Summary

An ongoing clinical trial from Zhujiang Hospital is evaluating whether gut microbiota modulates immune responses in patients with monoclonal gammopathy, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma

Snippet

Sponsor: Zhujiang Hospital | Conditions: Multiple Myeloma, MGUS | Status: RECRUITING